Used as an intermediate and amine protecting group (tert-butyl carbamate, Boc) in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules with 1,3-benzodioxole structures targeting central nervous system disorders, such as antidepressants or mood stabilizers. The Boc group offers stability under various conditions and can be deprotected under controlled acidic conditions. Its overall structure allows for selective modification in drug design, enhancing metabolic stability and receptor binding affinity. Commonly employed in research settings for creating analogs of natural products, peptide synthesis, and exploring structure-activity relationships in medicinal chemistry.